Stay Informed on Corporate Sustainability

Author: Bianca Odron

CCRM, OmniaBio and Avectas will evaluate an automated manufacturing platform designed for cell therapy production. The collaboration reflects growing industry focus on scalability, standardisation and manufacturing efficiency in advanced therapies.

Author: Bianca Odron

Jazz Pharmaceuticals and PharmaMar reported a Phase III setback for Zepzelca in relapsed small-cell lung cancer. The outcome highlights ongoing pressure on oncology development, evidence requirements and treatment competition.

Author: Bianca Odron

WuXi Biologics secured both Life Sciences Team of the Year and Overall Excellence in Life Sciences at the Life Sciences Industry Awards 2026, recognising the outstanding achievements of its Manufacturing Science & Technology Team.

Author: Bianca Odron

Ireland has the potential to expand its role in cannabinoid medicine manufacturing through investment, regulation and scientific expertise. Industry leaders say stronger support could help scale domestic pharmaceutical innovation.

Author: Bianca Odron

OEC trade data reveals Ireland as a pharmaceutical export giant, but US tariff pressure and supply chain concentration expose a structural vulnerability that national procurement leaders must plan around now.

Author: Bianca Odron

Áine Hopkins, VP of QA Operations at PTC Therapeutics, was named Best Quality Leadership winner at the Women in Pharma Awards 2026, recognising her outstanding contribution to quality excellence and organisational performance.

Author: Bianca Odron

Envirotainer has been announced as Gold Sponsor of the Pharma Industry Awards UK 2026, reflecting its long-standing commitment to excellence in pharmaceutical logistics and the safe delivery of life-saving medicines.

Author: Bianca Odron

Micro-Bio has been announced as Platinum Sponsor of the Pharma Industry Awards 2026, reinforcing its commitment to supporting excellence across Ireland's pharmaceutical and biopharmaceutical sectors. As Ireland's sole manufacturer of high-purity sodium hydroxide, hydrochloric acid and related products, Micro-Bio delivers traceable supply chains, GMP-controlled quality and tailored solutions for life sciences customers.

Author: Bianca Odron

The European Union is advancing legislation aimed at strengthening domestic medicine production and reducing supply chain dependence on China. The proposed measures could reshape pharmaceutical manufacturing and sourcing strategies across Europe.

Author: Archie Villaflores

Ireland’s NCPE led the first-ever EU Joint Clinical Assessment, approved on 30 April 2026 under the Health Technology Assessment Regulation. The milestone marks a strategic shift in how pharmaceutical companies must approach clinical evidence for EU-wide reimbursement.